◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Quest PharmaTech Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q4 2025Oct 31, 2025 Q2 2025Apr 30, 2025 Q1 2025Jan 31, 2025 Q4 2024Oct 31, 2024 Q3 2024Jul 31, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00
Operating Revenue 0.00 0.00 0.00 0.00 0.00
Selling General And Administration 180,703 60,532 175,656 142,559 119,256
General And Administrative Expense 180,703 60,532 175,656 142,559 119,256
Research And Development 59,874 56,500 101,500 102,750 60,392
Operating Expense 240,577 117,032 277,156 245,309 179,648
Operating Income -240,577 -117,032 -277,156 -245,309 -179,648
EBIT 1.1M 700,149 -1.7M 45,096 725,660
Interest Expense 5,105 5,072 121.00 10,367 6,098
Interest Expense Non Operating 5,105 5,072 121.00 10,367 6,098
Net Interest Income -5,105 -5,072 -121.00 -10,367 -6,098
Other Income Expense 1.3M 817,181 -1.4M 290,405 905,308
Other Non Operating Income Expenses 75,000 75,000 75,000 75,000 75,000
Gain On Sale Of Security 1.00 686,377 -457,165 4.00 396,254
Earnings From Equity Interest 1.2M 55,804 -1.0M 215,401 434,054
Pretax Income 1.1M 695,077 -1.7M 34,729 719,562
Tax Provision 0.00 0.00 0.00 0.00 0.00
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation 1.1M 695,077 -1.7M 34,729 719,562
Net Income From Continuing Operation Net Minority Interest 1.1M 695,077 -1.7M 34,729 719,562
Net Income Including Noncontrolling Interests 1.1M 695,077 -1.7M 34,729 719,562
Net Income Common Stockholders 1.1M 695,077 -1.7M 34,729 719,562
Net Income 1.1M 695,077 -1.7M 34,729 719,562
EBITDA 1.1M 700,149 -1.7M 45,096 725,660
Normalized EBITDA 1.1M 13,772 -1.2M 45,092 329,406
Reconciled Depreciation -- -- 0.00 0.00 0.00
Basic EPS 0.01 0.00 -- 0.00 0.00
Diluted EPS 0.01 0.00 -- 0.00 0.00
Basic Average Shares 169.1M 169.1M -- 169.1M 169.1M
Diluted Average Shares 169.1M 169.1M -- 169.1M 169.1M
Total Unusual Items 1.00 686,377 -457,165 4.00 396,254
Total Unusual Items Excluding Goodwill 1.00 686,377 -457,165 4.00 396,254
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00
Normalized Income 1.1M 8,700 -1.2M 34,725 323,308
Diluted NI Availto Com Stockholders 1.1M 695,077 -1.7M 34,729 719,562
Net Income Continuous Operations 1.1M 695,077 -1.7M 34,729 719,562
Net Non Operating Interest Income Expense -5,105 -5,072 -121.00 -10,367 -6,098
Other Gand A 180,703 60,532 175,656 142,559 119,256
Total Expenses 240,577 117,032 277,156 245,309 179,648
Total Operating Income As Reported -240,577 -117,032 -277,156 -245,309 -179,648
Line Item Q4 2025Oct 31, 2025 Q2 2025Apr 30, 2025 Q1 2025Jan 31, 2025 Q4 2024Oct 31, 2024 Q3 2024Jul 31, 2024
Cash And Cash Equivalents 58,241 59,096 205,085 186,356 321,431
Cash Cash Equivalents And Short Term Investments 58,241 59,096 205,085 186,356 321,431
Cash Financial 58,241 59,096 205,085 186,356 321,431
Receivables -- -- -- 125,000 100,000
Prepaid Assets 25,463 20,194 20,194 27,759 4,660
Current Assets 83,704 79,290 225,279 339,115 426,091
Investments And Advances 24.2M 23.1M 22.3M 23.9M 23.6M
Long Term Equity Investment 6.5M 17.7M 5.3M 5.7M 5.8M
Total Non Current Assets 24.2M 23.1M 22.3M 23.9M 23.7M
Total Assets 24.3M 23.2M 22.6M 24.2M 24.1M
Current Debt 1.0M 1.0M 1.0M 1.0M 1.0M
Current Debt And Capital Lease Obligation 1.0M 1.0M 1.0M 1.0M 1.0M
Payables And Accrued Expenses 253,864 69,462 168,343 81,642 71,939
Current Liabilities 1.3M 1.1M 1.2M 1.1M 1.1M
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00 0.00
Total Liabilities Net Minority Interest 1.3M 1.1M 1.2M 1.1M 1.1M
Common Stock 30.7M 30.7M 30.7M 30.7M 30.7M
Capital Stock 30.7M 30.7M 30.7M 30.7M 30.7M
Additional Paid In Capital 11.8M 11.7M 11.7M 11.7M 11.6M
Retained Earnings -19.3M -153,036 -20.9M -19.2M -19.2M
Gains Losses Not Affecting Retained Earnings -144,641 -20.2M -151,471 -118,373 -114,748
Other Equity Adjustments -144,641 -20.2M -151,471 -118,373 -114,748
Common Stock Equity 23.1M 22.1M 21.4M 23.1M 23.0M
Stockholders Equity 23.1M 22.1M 21.4M 23.1M 23.0M
Total Equity Gross Minority Interest 23.1M 22.1M 21.4M 23.1M 23.0M
Total Capitalization 23.1M 22.1M 21.4M 23.1M 23.0M
Net Tangible Assets 23.1M 22.1M 21.4M 23.1M 23.0M
Tangible Book Value 23.1M 22.1M 21.4M 23.1M 23.0M
Working Capital -1.2M -990,172 -943,064 -742,527 -645,848
Invested Capital 24.1M 23.1M 22.4M 24.1M 24.0M
Total Debt 1.0M 1.0M 1.0M 1.0M 1.0M
Net Debt 941,759 940,904 794,915 813,644 678,569
Share Issued 169.1M 169.1M 169.1M 169.1M 169.1M
Ordinary Shares Number 169.1M 169.1M 169.1M 169.1M 169.1M
Held To Maturity Securities 17.7M 5.3M 17.0M 18.1M 17.8M
Investmentin Financial Assets 17.7M 5.3M 17.0M 18.1M 17.8M
Non Current Prepaid Assets 5,855 5,855 5,855 5,855 5,855
Other Current Borrowings 1.0M 1.0M 1.0M 1.0M 1.0M
Other Receivables -- -- -- 125,000 100,000
Line Item Q4 2025Oct 31, 2025 Q2 2025Apr 30, 2025 Q1 2025Jan 31, 2025 Q4 2024Oct 31, 2024 Q3 2024Jul 31, 2024
Operating Cash Flow -34,999 -145,989 18,729 -135,075 -184,544
Cash Flow From Continuing Operating Activities -34,999 -145,989 18,729 -135,075 -184,544
Depreciation And Amortization -- -- 0.00 0.00 0.00
Depreciation Amortization Depletion -- -- 0.00 0.00 0.00
Stock Based Compensation 80,000 -- 0.00 84,000 0.00
Change In Working Capital 55,682 -98,881 119,273 -38,403 -73,798
Change In Receivables 0.00 -- 25,000 -25,000 0.00
Change In Payables And Accrued Expense 76,083 -98,881 86,708 9,696 -80,761
Investing Cash Flow 0.00 0.00 0.00 0.00 0.00
Issuance Of Debt -- -- 0.00 0.00 0.00
Repayment Of Debt -- -- 0.00 0.00 0.00
Net Issuance Payments Of Debt -- -- 0.00 0.00 0.00
Financing Cash Flow 0.00 0.00 0.00 0.00 0.00
Cash Flow From Continuing Financing Activities -- -- 0.00 0.00 0.00
Changes In Cash -34,999 -145,989 18,729 -135,075 -184,544
Beginning Cash Position 93,240 205,085 186,356 321,431 505,975
End Cash Position 58,241 59,096 205,085 186,356 321,431
Free Cash Flow -34,999 -145,989 18,729 -135,075 -184,544
Income Tax Paid Supplemental Data -- -- -- -- 0.00
Interest Paid Supplemental Data -- -- -- -- 0.00
Amortization Cash Flow -- -- 0.00 0.00 0.00
Amortization Of Intangibles -- -- 0.00 0.00 0.00
Change In Prepaid Assets -20,401 0.00 7,565 -23,099 6,963
Earnings Losses From Equity Investments -1.2M -55,804 876,546 63,173 -434,054
Net Income From Continuing Operations 1.1M 695,077 -1.7M 34,729 719,562
Net Short Term Debt Issuance -- -- 0.00 0.00 0.00
Operating Gains Losses -1.2M -55,804 876,546 63,173 -434,054
Short Term Debt Issuance -- -- 0.00 0.00 0.00
Short Term Debt Payments -- -- 0.00 0.00 0.00
Unrealized Gain Loss On Investment Securities 0.00 -686,381 -- -278,574 -396,254
NEWS
Loading news...
TRENDING
Loading...